Exawizards Inc.
PulseAugur coverage of Exawizards Inc. — every cluster mentioning Exawizards Inc. across labs, papers, and developer communities, ranked by signal.
- 2026-08-20 regulatory Exawizards Inc. has begun consultations with the Pharmaceuticals and Medical Devices Agency for its AI dementia diagnostic app. source
1 day(s) with sentiment data
-
Exawizards appoints Kazuo Senda to lead AI & DX Research Institute
Exawizards Inc. has appointed Kazuo Senda as the director of its Hataraku AI & DX Research Institute. Senda, author of "HR Systems Beneficial to Management," will leverage his expertise to advance the institute's focus …
-
Exawizards Inc. seeks AI dementia app approval by FY2026
Exawizards Inc. is aiming to receive approval for its AI-powered dementia diagnostic application by the end of fiscal year 2026. The company has initiated consultations with the Pharmaceuticals and Medical Devices Agenc…
-
Microsoft claims AI query energy use is minimal, up to 20x lower than estimates
Microsoft has asserted that the energy consumption of a single AI query is minimal, comparable to running a microwave for a few seconds. This claim suggests that the power usage for AI interactions is up to 20 times les…
-
ExaWizards launches Custom Agent feature for exaBase AI
ExaWizards has launched a new "Custom Agent" feature for its exaBase generative AI platform. This enhancement allows users to create personalized AI agents tailored to specific tasks and workflows. The company aims to e…